RxSight
RXST
164 hedge funds and large institutions have $235M invested in RxSight in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 31 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 54
3.35% more ownership
Funds ownership: 89.2% → 92.56% (+3.4%)
10% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 31
1% more funds holding
Funds holding: 163 → 164 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
38% less capital invested
Capital invested by funds: $382M → $235M (-$147M)
81% less call options, than puts
Call options by funds: $75K | Put options by funds: $392K
Top Buyers
Top Sellers
| 1 |
DCM
Defilade Capital Management
Emeryville,
California
|
-$9.51M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$5.57M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.13M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.83M |
| 5 |
Barclays
London,
United Kingdom
|
-$3.76M |
RXST Hedge Fund Activity: Q1 2026 in Review
164 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2026, worth a combined $235M — down 38% from $382M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new RXST positions and 31 closed out — a net gain of 3 holders — while 63 added to existing stakes and 54 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, adding an estimated $8.3M. The largest seller was Defilade Capital Management, exiting entirely with an estimated $9.51M sold.
- 164 institutional investors held RxSight (RXST) as of Q1 2026, up from 163 in Q4 2025.
- Funds reported $235M of RxSight stock for Q1 2026, down 38% quarter-over-quarter.
- 34 funds opened new RxSight positions in Q1 2026 and 31 closed out, a net change of +3 holders.
- The largest RxSight buyer in Q1 2026 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $8.3M added.
- The largest RxSight seller in Q1 2026 was Defilade Capital Management, an estimated $9.51M sold.
Based on aggregated 13F filings for Q1 2026.